Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl (Q43792316)

26 November 2017

title

Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl (English)

1 reference

26 November 2017

Ying-Jung Chen

1

1 reference

26 November 2017

Long-Sen Chang

series ordinal

2

1 reference

26 November 2017

publication date

3 August 2012

1 reference

Molecular Nutrition and Food Research

26 November 2017

published in

1 reference

26 November 2017

volume

56

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

1398-1412

1 reference

Enzymology of gallotannin and ellagitannin biosynthesis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Inhibitory effect of methyl gallate and gallic acid on oral bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Selective induction of cell death in cancer cells by gallic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid provokes DNA damage and suppresses DNA repair gene expression in human prostate cancer PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Important therapeutic targets in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the up-regulation of beta-transducin repeat-containing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

The AP-1 site and MMP gene regulation: what is all the fuss about?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

A role for AP-1 in matrix metalloproteinase production and invadopodia formation of v-Crk-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Emerging roles of ATF2 and the dynamic AP1 network in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Intestinal absorption of p-coumaric and gallic acids in rats after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Transepithelial transport of p-coumaric acid and gallic acid in Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

The safety and efficacy of a dietary herbal supplement and gallic acid for weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Green tea catechins as novel antitumor and antiangiogenic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Matrix metalloproteinase inhibition by green tea catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Regulation of matrix metalloproteinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200167

21 January 2018

Identifiers

DOI

10.1002/MNFR.201200167

1 reference

26 November 2017

1 reference